Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Apoptosis : an International Journal on Programmed Cell Death
|
September 17, 2015
Replication-competent adenoviruses with the type 35-derived fiber-knob region achieve reactive oxygen species-dependent cytotoxicity and produce greater toxicity than those with the type 5-derived region in pancreatic carcinoma
Suguru Yamauchi, Kiyoko Kawamura, Shinya Okamoto, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 21, 2015
A combinatory use of adenoviruses expressing melanoma differentiation-associated gene-7 and replication-competent adenoviruses produces synergistic effects on pancreatic carcinoma cells
Guangyu Ma, Boya Zhong, Shinya Okamoto, et al.
Oncotarget
|
June 15, 2018
Heat shock protein 90 inhibitors augment endogenous wild-type p53 expression but down-regulate the adenovirally-induced expression by inhibiting a proteasome activity
Kuan Chai, Xuerao Ning, Thảo Thi Thanh Nguyễn, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 16, 2011
ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity
Hideki Kimura, Takahiro Nakajima, Kengo Takeuchi, et al.
Annals of Nuclear Medicine
|
January 2, 2021
Clinical value of PET/CT with carbon-11 4DST in the evaluation of malignant and benign lung tumors
Ryuichi Nishii, Tsuneo Saga, Hitomi Sudo, et al.
JTO Clinical and Research Reports
|
April 6, 2026
Clinical Concordance of Pan Lung Cancer PCR Panel Covering 167 Actionable Variants Across 11 Genes and Other Validated Assays in the LC-SCRUM-Asia Registry
Shingo Matsumoto, Takashi Seto, Christer Svedman, et al.
International Journal of Clinical Oncology
|
March 5, 2019
Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC
Shunichi Sugawara, Kazuhiko Nakagawa, Nobuyuki Yamamoto, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 18, 2024
Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia
Yuki Kato, Hibiki Udagawa, Shingo Matsumoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 12, 2024
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of Gedatolisib
Shigeki Umemura, Hibiki Udagawa, Takaya Ikeda, et al.
JTO Clinical and Research Reports
|
October 24, 2022
Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data
Hideki Terai, Kenzo Soejima, Asanao Shimokawa, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Apoptosis : an International Journal on Programmed Cell Death
|
September 17, 2015
Replication-competent adenoviruses with the type 35-derived fiber-knob region achieve reactive oxygen species-dependent cytotoxicity and produce greater toxicity than those with the type 5-derived region in pancreatic carcinoma
Suguru Yamauchi, Kiyoko Kawamura, Shinya Okamoto, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 21, 2015
A combinatory use of adenoviruses expressing melanoma differentiation-associated gene-7 and replication-competent adenoviruses produces synergistic effects on pancreatic carcinoma cells
Guangyu Ma, Boya Zhong, Shinya Okamoto, et al.
Oncotarget
|
June 15, 2018
Heat shock protein 90 inhibitors augment endogenous wild-type p53 expression but down-regulate the adenovirally-induced expression by inhibiting a proteasome activity
Kuan Chai, Xuerao Ning, Thảo Thi Thanh Nguyễn, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 16, 2011
ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity
Hideki Kimura, Takahiro Nakajima, Kengo Takeuchi, et al.
Annals of Nuclear Medicine
|
January 2, 2021
Clinical value of PET/CT with carbon-11 4DST in the evaluation of malignant and benign lung tumors
Ryuichi Nishii, Tsuneo Saga, Hitomi Sudo, et al.
JTO Clinical and Research Reports
|
April 6, 2026
Clinical Concordance of Pan Lung Cancer PCR Panel Covering 167 Actionable Variants Across 11 Genes and Other Validated Assays in the LC-SCRUM-Asia Registry
Shingo Matsumoto, Takashi Seto, Christer Svedman, et al.
International Journal of Clinical Oncology
|
March 5, 2019
Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC
Shunichi Sugawara, Kazuhiko Nakagawa, Nobuyuki Yamamoto, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 18, 2024
Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia
Yuki Kato, Hibiki Udagawa, Shingo Matsumoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 12, 2024
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of Gedatolisib
Shigeki Umemura, Hibiki Udagawa, Takaya Ikeda, et al.
JTO Clinical and Research Reports
|
October 24, 2022
Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data
Hideki Terai, Kenzo Soejima, Asanao Shimokawa, et al.
Page
of 5